| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
204,316
|
207,986
|
199,769
|
201,397
| | Cost of Revenue | 158,324 | 158,684 | 152,887 | 153,551 | | |
Gross Profit
|
45,992
|
49,303
|
46,881
|
47,846
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 41,736 | 38,905 | 36,584 | 37,644 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 2,466 | 2,713 | 2,696 | 2,937 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,791
|
7,685
|
7,601
|
7,265
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (439) | 327 | 425 | 167 |
|
Earnings Before Interest And Taxes | 1,352 | 8,012 | 8,026 | 7,432 |
|
Interest Expense | 485 | 487 | 592 | 660 |
|
Income Before Tax | 867 | 7,525 | 7,434 | 6,771 |
|
Income Tax Expense | (28) | 1,551 | 2,457 | 2,297 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 895 | 5,973 | 4,976 | 4,474 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
895
|
5,973
|
4,976
|
4,474
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
895
|
5,973
|
4,976
|
4,474
|
|
0.04(0.37%) 11:17AM EDT - Nasdaq Real Time Price